The Cancer Therapeutics Training (CT2) Program is an NIH-funded training program in cancer therapeutic development. This program accepts both PhD, PharmD and MD post-doctoral researchers.
We are now accepting applications for the 3 training positions available July 1, 2013.
Please note, the application deadline has been extended to April 15, 2013.
We accept applications on a rolling basis, but trainees interested in the July 1, 2013, start date should submit their completed applications no later than April 15, 2013. For further information, please contact the CT2 program manager, Angela Robles at email@example.com.
CT2 applicants must be United States citizens, noncitizen nationals or have been lawfully admitted for permanent residence by the time of their appointment.
Non-citizen nationals are people, who, although not citizens of the United States, owe permanent allegiance to the United States. They are generally people born in outlying possessions of the United States (e.g., American Samoa and Swains Island). Individuals who have been lawfully admitted for permanent residence must have a currently valid Alien Registration Receipt Card (I-551) or other legal verification of such status.
Sorry, but individuals on temporary or student visas are NOT eligible for CT2 support.
Prior Ruth L. Kirschstein-NRSA support
If you have previously been supported by a National Research Service Award (now known as Ruth L. Kirschstein National Research Service Award), please be aware that you may not have completed more than 5 years of combined support at the pre-doctoral level or 1 year of combined support at the post-doctoral level. As the CT2 program requires a two-year commitment, trainees must be eligible for a full 24 months of Kirschstein-NRSA support.
PhD applicants may not have completed more than 3 years of post-doctoral training.
All CT2 applicants must identify a faculty mentor prior to having their application reviewed by the Executive Committee. Please contact the mentor in whose laboratory you wish to complete your research prior to submitting your application. A letter from your mentor is required to move your application forward.
If you would like to be considered for a training position please identify a faculty mentor and send,
- Completed application form (with faculty mentor identified)
- Curriculum Vitae
- A one-page personal statement
- Graduate School Transcript
- Proof of U.S. Citizenship/Residency
- 3 letters of recommendation (one from your faculty mentor)
via e-mail (preferred), mail or fax to:
The Cancer Therapeutics Training Program
c/o Angela Robles
UC San Diego Moores Cancer Center
3855 Health Sciences Drive, #0819
La Jolla, California, USA 92093-0819
For further information, please contact the CT2 Program Manager, Angela Robles, via email at firstname.lastname@example.org or via telephone at 858-822-1110.